Tilray Medical (NASDAQ: TLRY), a leading provider of certified medicinal cannabis in the world, has expanded its European presence through a new distribution partnership with Cansativa Group.

The new partnership will enable Tilray to distribute its comprehensive portfolio of medical cannabis products to more patients in the Czech Republic, who may access them by consulting their healthcare practitioner. 

Tilray Chief Strategy Officer, Denise Faltischek stated: We are extremely proud to broaden our distribution across the Czech Republic and offer our EU-GMP certified medicinal cannabis products to help support medical cannabis patients in need. Our Tilray Medical team remains dedicated to patient advocacy across our international markets by providing quality medicinal cannabis for commercial, compassionate access, and research purposes."

Tilray is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in over 20 countries and across five continents. A pioneer in cannabis research, Tilray has operations in Canada, the United States, Europe, Australia, and Latin America.

Shares of Tilray trade on the NASDAQ under the ticker symbol TLRY.